Changes to how EU rules are implemented could allow children access to a goldmine of potential cancer drugs which have currently only been tested in adults – by making it more difficult for pharma companies to avoid testing them in under-18s too.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…